It was found that administration of paeoniflorin can inhibit the activity of the high-mobility group box 1 protein/TLR4/NF-κB pathway and alleviate the level of inflammation in the serum and hippocampus, thereby treating lupus-induced depression [32]. Here, TLR4 is linked to major depressive disorder.